Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.
Press releases published on August 13, 2025
NJ Top Dentists Approves Joseph Moussa, DDS, FICOI For 2025 Based On Merit
EIN Presswire
·
August 13, 2025
NJ Top Dentists has recognized Joseph Moussa, DDS, FICOI of Montclair Dental Spa for 2025. MONTCLAIR, NJ, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Joseph Moussa, DDS, FICOI has been reviewed and approved as a 2025 NJ Top Dentist, recognized …
Dr. Cecilio P. Po of GPC Dental Awarded As 2025 NJ Top Dentist
EIN Presswire
·
August 13, 2025
NJ Top Dentists has reviewed and approved Dr. Cecilio P. Po of GPC Dental based on merit for 2025. CEDAR GROVE, NJ, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- GPC Dental is proud—and absolutely thrilled—to announce that Dr. Cecilio Po has been …
Neuronascent Announces Progress for Lead Candidate NNI-362: Publication of Phase 1a Clinical Trial Results and FDA Grants Waiver of Fee for Canine Cognitive Disorder 2025 Submissions
GlobeNewswire
·
August 13, 2025
BALTIMORE., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Neuronascent Inc., a privately-held neuron regeneration therapeutics company, today announced that the Phase 1a trial in aged human subjects of its NNI-362 therapy was published in Alzheimer’s Research and …
Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex
GlobeNewswire
·
August 13, 2025
Denali’s registration statement on Form S-4 declared effective by the Securities and Exchange Commission Extraordinary general meeting of Denali Capital Acquisition Corp. shareholders to approve the proposed business combination is scheduled to be held on …
Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania
GlobeNewswire
·
August 13, 2025
STAFFORD, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy …
LIO Launches Next-Generation Inpatient Mental Health Platform with Advanced Rounding, Monitoring, and Compliance Tools
GlobeNewswire
·
August 13, 2025
WILMINGTON, Del., Aug. 13, 2025 (GLOBE NEWSWIRE) -- LIO today announced the launch of its new all-in-one platform for inpatient mental health services, featuring a compliance reporting suite, next generation digital observations, and adaptive monitoring …
Corza Medical Launches Biomedical Textiles Innovation Lab to Accelerate OEM Product Development
GlobeNewswire
·
August 13, 2025
TAUNTON, U.K., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a leading global manufacturer of surgical technologies and medical device components announced today the launch of its Biomedical Textiles Innovation Lab, a state-of-the-art facility designed …
Greywolf Therapeutics begins dosing of the first treatment to target the antigenic source of autoimmunity
GlobeNewswire
·
August 13, 2025
This is the first ever autoimmunity study to evaluate a potential functional cure that targets the antigenic source – the origin of autoimmune disease The Phase 1/2 study (up to 141 participants) will evaluate the safety, tolerability and efficacy of …
Santhera schließt Vereinbarung mit GEN über den Vertrieb von AGAMREE® (Vamorolon) in der Türkei
GlobeNewswire
·
August 13, 2025
Pratteln, Schweiz, 13. August 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt die Unterzeichnung einer exklusiven Vereinbarung mit Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) über den Vertrieb und die Vermarktung von AGAMREE® (Vamorolon) in der …
Santhera Secures Agreement with GEN for the Distribution of AGAMREE® (Vamorolone) in Türkiye
GlobeNewswire
·
August 13, 2025
Pratteln, Switzerland, 13 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) for the distribution and promotion of AGAMREE® (vamorolone) in Türkiye …
Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering
GlobeNewswire
·
August 13, 2025
BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today …
Global High-Throughput Screening Market to Surpass USD 50.2 Billion by 2029 | MarketsandMarkets™.
GlobeNewswire
·
August 13, 2025
Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- North America Leads Today, Asia Pacific to Record Fastest Growth The global high throughput screening market, valued at US$25.7 billion in 2023, stood at US$28.8 billion in 2024 and is projected to …